Findings from a study published in the Annals of Allergy, Asthma & Immunology suggest the ongoing difficulty in diagnosing anaphylaxis as evident by the low prescribing rates of epinephrine ...
Credit: Shutterstock. This clinical report from the American Academy of Pediatrics is an update on their 2007 clinical report. HealthDay News — All caregivers for children at risk of anaphylaxis ...
AUVI-Q (R) (epinephrine injection, USP) is still available by prescription for children with life-threatening allergies. Most kids spend the final weeks of summer amassing school supplies and cramming ...
NHSBSA prescription data drives clinical research to enhance anaphylaxis management and patient safety14 January 2026Two new research papers show how NHS Business Services Authority (NHSBSA) ...
Dublin, April 30, 2020 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injector Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The Global ...
A company beneath the umbrella of pharmaceutical giant Pfizer has initiated a clawback of its recalled EpiPen Auto-Injector and EpiPen Jr Auto-Injector for failing to activate in time of need. The U.S ...
Pro Football Player Adrian Peterson is Calling on Americans to be Ready2Go™ and Learn How to be Aware and Prepared for Anaphylaxis PITTSBURGH, June 2, 2014 /PRNewswire/ -- Mylan Specialty, the fully ...
Anaphylaxis can cause severe itching, difficulty breathing, fainting, and abdominal pain. These symptoms usually begin about 30 minutes after coming into contact with an allergy trigger. First, call ...
New Multi-year Alliance to Increase Anaphylaxis Awareness through Multiple Educational Initiatives PITTSBURGH, Nov. 7, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced it has signed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback